Company Profile
Eloxx Stock Price, News & Analysis
- Ticker:
- ELOX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
17.88 USD (-2.98%)
Close
Last updated: August 5, 2026
—
Market cap
Why the stock is moving
As of Aug 5, 2026, ELOX closed down 2.98% at $17.88. No new same-company headline was identified in the current news window.
Company overview
Business overview
Eloxx Pharmaceuticals was a biotechnology company focused on rare disease and nonsense-mutation biology. Its story was built around precision approaches to difficult inherited disorders.
Geographic Base and Sector Classification
Eloxx was headquartered in the United States and listed on NASDAQ. It sat in rare-disease biotechnology.
Business Model Characteristics
The business depended on translational progress, clinical validation, and the ability to keep a narrow pipeline funded. Investors generally watched early data and strategic changes.
Position Within the Biotechnology Landscape
Eloxx occupies the historical rare-disease biotech bucket. Its value proposition was always tied to limited assets and the market's patience for development risk.
Future catalysts
Eloxx’s catalysts are its nonsense-mutation and rare-disease pipeline, plus any update that clarifies whether the company can still keep the translational story alive. The next step matters because the company still needs clinical proof.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Eloxx (ELOX)?
Eloxx (ELOX) most recently closed at 17.88 USD, a -2.98% move versus the previous session.
What does Eloxx do?
Eloxx Pharmaceuticals was a biotechnology company focused on rare disease and nonsense-mutation biology. Its story was built around precision approaches to difficult inherited disorders.
On which exchange is ELOX stock listed?
Eloxx (ELOX) is associated with NASDAQ, United States, Biopharma.
What is Eloxx?
Eloxx’s catalysts are its nonsense-mutation and rare-disease pipeline, plus any update that clarifies whether the company can still keep the translational story alive.
Which conditions is Eloxx targeting with Eloxx?
Eloxx is associated with rare disease based on its company overview and current catalyst commentary.
How does Eloxx describe recent progress with Eloxx?
Eloxx’s catalysts are its nonsense-mutation and rare-disease pipeline, plus any update that clarifies whether the company can still keep the translational story alive.
What is Pharmaceuticals?
Eloxx Pharmaceuticals was a biotechnology company focused on rare disease and nonsense-mutation biology.
What should investors watch for with Pharmaceuticals?
Eloxx’s catalysts are its nonsense-mutation and rare-disease pipeline, plus any update that clarifies whether the company can still keep the translational story alive. The next step matters because the company still needs clinical proof.